Acquired von Willebrand disease - Hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion

American Journal of Hematology

Volumn 70, Issue 1, 2002, Pages 64-71

  Sigler, Erica ^a,b   Shaft, Dina ^a   Shtalrid, Mordechai ^b   Shvidel, Lev ^a   Berrebi, Alain ^a   Resnitzky, Peretz ^a,b  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Acquired von Willebrand disease; Continuous infusion; Desmopressin; High dose immunoglobulin; Surgery; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8 CONCENTRATE; DESMOPRESSIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN LAMBDA CHAIN; RISTOCETIN; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLEEDING DISORDER; BLOOD CLOTTING; CASE REPORT; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG INFUSION; DRUG MEGADOSE; FEMALE; HALF LIFE TIME; HEMOSTASIS; HIP SURGERY; HUMAN; HUMAN TISSUE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; ORTHOPEDIC SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STEADY STATE; SUBSTITUTION THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ARTHROPLASTY, REPLACEMENT, HIP; DEAMINO ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FACTOR VIII; FEMALE; HEMOSTASIS; HEMOSTATICS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; TREATMENT OUTCOME; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0036235777     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10074     Document Type: Article

References (30)

1. Acquired von Willebrand syndrome: From pathophysiology to management
2. Acquired von Willebrand syndrome: Data from an international registry
3. Acquired von Willebrand syndrome - Report of 10 cases and review of the literature
4. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease
5. Efficacy of high-dose intravenous gammaglobulin in the management of acquired von Willebrand's disease during orthopaedic surgery
6. Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate
7. High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease
8. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: Comparison of three different therapeutic approaches
9. High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease
10. Continuous infusion therapy with very high purity von Willebrand factor concentrate in patients with severe von Willebrand disease
11. Safety and efficacy of continuous infusion of a combined factor VIII - Von Willebrand factor (vWF) concentrate (Haemate-P) in patients with von Willebrand disease
12. Stability of Factor VIII concentrates - Preconditions for continuous infusion regimens
13. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A
14. Kontinuierliche infusion von faktorenkonzentraten nach operation bei kindern mit hämophilie
15. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery
16. Screening for von Willebrand disease with a new analyzer using high shear stress: A study of 60 cases
17. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease
18. Variant von Willebrand's disease: Characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets
19. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes
20. Impact, diagnosis and treatment of von Willebrand disease
21. Continuous intravenous infusion of factor VIII in classic haemophilia
22. Experience with Haemate P in von Willebrand's disease in adults
23. Therapy of von Willebrand disease
24. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates
25. Characterization of factor VIII/von Willebrand factor concentrates using a modified method of von Willebrand factor multimer analysis
26. Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease
27. The use of intermediate and high purity factor VIII products in the treatment of von Willebrand disease
28. A perspective on the use of FVIII concentrates and cryoprecipitate prophylactically in surgery or therapeutically in severe bleeds in patients with von Willebrand disease unresponsive to DDAVP: Results of an international survey
29. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: A double-blind, randomized comparison
30. Venous thromboembolism after hip fracture surgery in a patient with haemophilia B and factor V Arg506Gln (factor V Leiden)